Humalog Mix 50 Kwikpen 100IU/ml is a premixed insulin formulation containing 50% insulin lispro and 50% insulin lispro protamine suspension, designed for the management of diabetes mellitus requiring insulin therapy. Insulin lispro is a rapid-acting insulin analogue that facilitates prompt postprandial glucose control by promoting cellular glucose uptake and inhibiting hepatic glucose production shortly after administration. The protamine component, insulin lispro protamine, acts as an intermediate-acting insulin, providing a prolonged basal insulin effect to maintain glycemic control between meals and overnight. This combination allows for both rapid onset and sustained duration of action, making it suitable for patients who require both prandial and basal insulin coverage in a single injection. Humalog Mix 50 Kwikpen is administered subcutaneously and should be used according to individualized dosing regimens determined by healthcare professionals based on patient-specific glycemic targets, meal patterns, and lifestyle. Proper injection technique and rotation of injection sites are essential to optimize absorption and minimize lipodystrophy. Patients should monitor blood glucose regularly to adjust doses appropriately and avoid hypoglycemia. This product is contraindicated in patients with hypersensitivity to insulin lispro or any excipients. Caution is advised in patients with renal or hepatic impairment.